GDF2 and Pulmonary arterial hypertension associated with portal hypertension: Further studies, examining the longitudinal changes in plasma BMP9 levels in PoPH both after targeted therapy and following liver transplantation, will be required to fully define both the significance and clinical utility of this biomarker in PoPH.